Literature DB >> 25654320

Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges.

Lin-Ping Wu1, Mario Ficker2, Jørn B Christensen2, Panagiotis N Trohopoulos3, Seyed Moein Moghimi1,4.   

Abstract

Dendrimers are three-dimensional macromolecular structures originating from a central core molecule and surrounded by successive addition of branching layers (generation). These structures exhibit a high degree of molecular uniformity, narrow molecular weight distribution, tunable size and shape characteristics, as well as multivalency. Collectively, these physicochemical characteristics together with advancements in design of biodegradable backbones have conferred many applications to dendrimers in formulation science and nanopharmaceutical developments. These have included the use of dendrimers as pro-drugs and vehicles for solubilization, encapsulation, complexation, delivery, and site-specific targeting of small-molecule drugs, biopharmaceuticals, and contrast agents. We briefly review these advances, paying particular attention to attributes that make dendrimers versatile for drug formulation as well as challenging issues surrounding the future development of dendrimer-based medicines.

Mesh:

Substances:

Year:  2015        PMID: 25654320     DOI: 10.1021/acs.bioconjchem.5b00031

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  29 in total

1.  Self-assembly of four generations of RNA dendrimers for drug shielding with controllable layer-by-layer release.

Authors:  Xin Li; Mario Vieweger; Peixuan Guo
Journal:  Nanoscale       Date:  2020-07-30       Impact factor: 7.790

Review 2.  Multivalent Inhibitors of Channel-Forming Bacterial Toxins.

Authors:  Goli Yamini; Ekaterina M Nestorovich
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

3.  Carbon nanodots as molecular scaffolds for development of antimicrobial agents.

Authors:  Maria Ngu-Schwemlein; Suk Fun Chin; Ryan Hileman; Chris Drozdowski; Clint Upchurch; April Hargrove
Journal:  Bioorg Med Chem Lett       Date:  2016-02-18       Impact factor: 2.823

Review 4.  Polyplex Evolution: Understanding Biology, Optimizing Performance.

Authors:  Arnaldur Hall; Ulrich Lächelt; Jiri Bartek; Ernst Wagner; Seyed Moein Moghimi
Journal:  Mol Ther       Date:  2017-03-06       Impact factor: 11.454

Review 5.  Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.

Authors:  Piper A Rawding; Jiyoon Bu; Jianxin Wang; Da Won Kim; Adam J Drelich; Youngsoo Kim; Seungpyo Hong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-08-19

Review 6.  Promising Therapeutic Strategies for Colorectal Cancer Treatment Based on Nanomaterials.

Authors:  Natalia Krasteva; Milena Georgieva
Journal:  Pharmaceutics       Date:  2022-06-07       Impact factor: 6.525

7.  Design strategies for chemical-stimuli-responsive programmable nanotherapeutics.

Authors:  Muhammad Gulfam; Fitsum Feleke Sahle; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-10-05       Impact factor: 7.851

8.  A study on the hemocompatibility of dendronized chitosan derivatives in red blood cells.

Authors:  Yanfang Zhou; Jiemei Li; Fang Lu; Junjie Deng; Jiahua Zhang; Peijie Fang; Xinsheng Peng; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2015-05-14       Impact factor: 4.162

9.  Guest-Host Chemistry with Dendrimers—Binding of Carboxylates in Aqueous Solution.

Authors:  Mario Ficker; Johannes F Petersen; Jon S Hansen; Jørn B Christensen
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

Review 10.  Recent insights into nanotechnology development for detection and treatment of colorectal cancer.

Authors:  Buddolla Viswanath; Sanghyo Kim; Kiyoung Lee
Journal:  Int J Nanomedicine       Date:  2016-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.